PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 27(6): 619-624 2007
© 2007 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fieren, M. W.J.A.
Right arrow Articles by Boer, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fieren, M. W.J.A.
Right arrow Articles by Boer, W. H.

INVITED REVIEWS

POSTTRANSPLANT ENCAPSULATING PERITONEAL SCLEROSIS: A WORRYING NEW TREND?

Marien W.J.A. Fieren1, Michiel G.H. Betjes1, Mario R. Korte1 and Walther H. Boer2

Nephrology,1 Department of Internal Medicine, Erasmus Medical Center, Rotterdam; Department of Nephrology,2 University Medical Center, Utrecht, The Netherlands

Correspondence to: M.W.J.A. Fieren, Erasmus Medical Center, Room Bd 336, Post office Box 2040, 3000CA Rotterdam, The Netherlands. m.fieren{at}erasmusmc.nl

Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication in patients on peritoneal dialysis (PD). We describe a cluster of 13 EPS cases occurring in 2 university hospitals in The Netherlands. Most of these cases were diagnosed after recent kidney transplantation, when the patients developed severe symptoms of bowel obstruction. This accumulation raised the question as to whether other than known risk factors, such as duration of PD treatment, could be involved in the development or course of EPS after transplantation. According to various publications, EPS has been diagnosed often after withdrawal from PD, suggesting that cessation in itself may be a risk factor. In addition, transplantation-related management should be considered to play a role, including the use of the profibrotic calcineurin inhibitors and the trend to reduce the load of corticosteroids in treatment regimes. To identify risk factors, further multicenter studies are required, paying special attention to alterations in immunosuppressive treatment regimens as well as PD prescriptions, including PD fluid characteristics. Transfer from PD to hemodialysis should be under serious consideration in patients eligible for kidney transplantation as soon as there are indications of ultrafiltration failure.

KEY WORDS: Encapsulating peritoneal sclerosis; kidney transplantation; immunosuppressives; ultrafiltration failure.

Received 13 October 2006; accepted 20 July 2007.




This article has been cited by other articles:


Home page
NDT PlusHome page
D. de Freitas, T. Augustine, H. Hurst, P. Taylor, R. Williams, A. Hutchison, P. E. C. Brenchley, and A. M. Summers
Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy
NDT Plus, August 8, 2008; (2008) sfn109v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2007 by Multimed Inc.